![Stephanie Kenney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Stephanie Kenney is currently Chief Corporate Affairs Officer at Atrium Therapeutics, Inc. Formerly, Ms. Kenney was Vice President-Global Corporate Affairs at Hansa Biopharma AB from 2022 to 2025.
Ms. Kenney completed undergraduate studies at Mansfield University of Pennsylvania.
Postes actifs de Stephanie Kenney
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Stephanie Kenney
| Sociétés | Poste | Fin |
|---|---|---|
| HANSA BIOPHARMA AB | Public Communications Contact | 31/08/2025 |
Formation de Stephanie Kenney
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Mansfield University of Pennsylvania
 Mansfield University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Choisissez Zonebourse 
